Linda Zhong
Kowloon Tong, Kowloon, Hong Kong
NCT Number: NCT03815253
In this study, a 8-week, single blinded, randomized controlled clinical trial will be conducted to examine the efficacy and safety of body acupuncture in the treatment of central obesity in Hong Kong.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Kowloon Tong, Kowloon, Hong Kong
This is a pilot single-blind, randomized, sham-controlled trial. 168 central obesity patients will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 8 weeks with 2 session per week and the follow-up period will be 2 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients who meet all of the following criteria are defined as eligible participants: men and women aged between 18 and 65 years old; BMI ≥ 25 kg/m2; central obesity, defined as WC of ≥ 90 cm in men and ≥ 80 cm in non-pregnant women according to ICD-10 [24]; not receiving any other weight control measures or any medical and/or drug history in last 3months.
Exclusion criteria
Patients who meet any of the following criteria should be excluded from the study: endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc.; heart diseases, including arrhythmia, heart failure, myocardial infarction, patients with pacemaker; allergy and immunology diseases; bleeding tendency; pregnant or lactating women; impaired hepatic or renal function; stroke or unable to exercise.
Body electro-acupuncture will choose eight acupoints as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli (ST-36), Fenlong(ST-40), Sanyinjiao(SP-6).Disposable acupuncture needles (verum acupuncture needles asia-med Special No. 16 with 0.30 x 0.30mm matching the Streitberger sham-needles) will be inserted at a depth of 10-25 mm into the points.
We will also deliver electrical stimulation with dense-disperse waves with 50Hz at 10 volts through electrical acupuncture stimulation instrument (ES-160 6-Channel Programmable Electro-acupuncture) to the abdominal points. The bodily needles will be retained for 30 minutes.
Time frame: 0,1,2,3,4,5,6,7,8, 11, 15,18, 21, 24 weeks
Waist circumference will be measured around the abdomen at the level of the umbilicus (belly button).
Time frame: 0,1,2,3,4,5,6,7,8,9,11,15,18, 21, 24 weeks
hip circumference measured at the level of maximum posterior extension of the buttocks
Time frame: 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
Adverse events of acupuncture treatment will be assessed using the Treatment Emergent Symptom Scale (TESS) and would be evaluated during the whole procedure, as well as laboratory tests (whole blood counts, renal and liver functions) if needed. All clinical adverse events will be recorded in terms of intensity (mild, moderate, or severe), duration, outcome and relationship to the study.
Time frame: 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
waist-to-hip ratio is the dimensionless ratio of the circumference of the waist to that of the hips. This is calculated as waist measurement divided by hip measurement ( W ÷ H ).
Time frame: 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
Body Mass Index is a simple calculation using a person's height and weight. The formula is BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared.
Time frame: 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
The body fat percentage (BFP) of a human or other living being is the total mass of fat divided by total body mass, multiplied by 100. Body fat percentage will be measured by Omron Karada Scan HBF-701.
Time frame: 0, 8 weeks
Total cholesterol (TC), triglyceride (TG) and fasting blood glucose (FBG) will be measured before and after the 8-week treatment.
Hong Kong Baptist University
Other
Electro-acupuncture for Central Obesity: a Single Blinded Randomized Sham-controlled Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07486557
Body Weight, Central Obesity
Beijing, Beijing Municipality, China
View Trial DetailsNCT03912272
Body Weight, Central Obesity
Hong Kong
View Trial DetailsNCT02010060
Body Weight, Central Obesity
Greenville, North Carolina, United States
View Trial DetailsNCT02375113
Body Weight, Central Obesity
San Antonio, Texas, United States
View Trial Details